Glonghui May 14 丨 Shanghai Pharmaceutical (601607)(601607freeslotmachinegames.SH) announced that Changzhou Pharmaceutical Factory Co., Ltd., the company's holding subsidiary (hereinafter referred to as "Changzhou Pharmaceutical Factory")freeslotmachinegamesSacubatrivalsartan sodium tablets (hereinafter referred to as "the drug") received the "Drug Registration Certificate"(Certificate Nos.: 2024S00767, 2024S00768) issued by the State Food and Drug Administration, and the drug was approved for production. Sacubatryl Valsartan Sodium Tablets are mainly used to treat symptoms such as chronic heart failure and essential hypertension.